Can Fite Biopharma Stock Alpha and Beta Analysis
| CANF Stock | USD 2.20 0.10 4.76% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Can Fite Biopharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Can Fite over a specified time horizon. Remember, high Can Fite's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Can Fite's market risk premium analysis include:
Beta 0.8 | Alpha (0.11) | Risk 4.13 | Sharpe Ratio 0.0164 | Expected Return 0.0676 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Can |
Can Fite Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Can Fite market risk premium is the additional return an investor will receive from holding Can Fite long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Can Fite. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Can Fite's performance over market.| α | -0.11 | β | 0.80 |
Can Fite expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Can Fite's Buy-and-hold return. Our buy-and-hold chart shows how Can Fite performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Can Fite Market Price Analysis
Market price analysis indicators help investors to evaluate how Can Fite stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Can Fite shares will generate the highest return on investment. By understating and applying Can Fite stock market price indicators, traders can identify Can Fite position entry and exit signals to maximize returns.
Can Fite Return and Market Media
The median price of Can Fite for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 2.16 with a coefficient of variation of 11.12. The daily time series for the period is distributed with a sample standard deviation of 0.25, arithmetic mean of 2.23, and mean deviation of 0.2. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Join Can-Fites Exclusive Live Investor Webinar and QA Session on October 29 - StockTitan | 10/07/2024 |
2 | Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson | 10/18/2024 |
3 | Can-Fites namodenoson maintains stock target, buy rating after trial news | 11/12/2024 |
About Can Fite Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Can or other stocks. Alpha measures the amount that position in Can Fite Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2024 (projected) | Current Ratio | 7.35 | 3.66 | 3.69 | Net Debt To EBITDA | 0.33 | 0.29 | 0.78 |
Can Fite Upcoming Company Events
As portrayed in its financial statements, the presentation of Can Fite's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Can Fite's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Can Fite's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Can Fite. Please utilize our Beneish M Score to check the likelihood of Can Fite's management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 6th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Can Fite
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Can Fite Backtesting, Can Fite Valuation, Can Fite Correlation, Can Fite Hype Analysis, Can Fite Volatility, Can Fite History and analyze Can Fite Performance. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Can Fite technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.